A digital mammogram is a breast X-ray that captures images electronically instead of on film. Rather than developing a physical sheet of film like older mammography systems, digital mammography uses electronic detectors to convert X-rays into a digital image file that can be viewed on a high-resolution monitor, enhanced with software tools, and stored in a computer system. Today, virtually all mammography facilities in the United States use digital technology, and it has become the standard method for breast cancer screening.
How Digital Mammography Works
The experience of getting a digital mammogram feels identical to the older film version. You stand in front of the mammography unit while a technologist positions your breast on a flat platform. A compression plate presses the breast tissue flat for a few seconds per image, which spreads the tissue so overlapping structures don’t hide potential abnormalities. A standard screening exam takes four images: two of each breast from different angles.
The difference is what happens to the X-rays after they pass through your breast tissue. In a film mammogram, the X-rays expose a sheet of film directly. In a digital mammogram, they hit an electronic detector, either a flat panel made of selenium or silicon, that converts the X-ray energy into an electrical signal. That signal is then processed into a high-resolution image file. The radiologist reads these images on specialized monitors that display far more shades of gray than the human eye can distinguish on film.
This digital format gives radiologists tools that film never offered. They can zoom in on a suspicious area, adjust brightness and contrast, and invert the image so that white becomes black and vice versa. None of this changes the original data, it simply helps the reader see structures that might be subtle on a standard view.
Why Digital Outperforms Film
For the general screening population, digital and film mammography catch cancer at roughly the same rate. But digital mammography is significantly more accurate for three groups: women under 50, women with dense breast tissue, and premenopausal or perimenopausal women. A landmark trial published in the New England Journal of Medicine found that digital mammography’s accuracy was meaningfully higher in all three of these groups compared to film.
The reason comes down to contrast. Dense breast tissue appears white on a mammogram, and so do many tumors. On film, these white-on-white patterns are difficult to distinguish. Digital detectors capture a wider range of contrast, making it easier for the radiologist to separate dense normal tissue from something that warrants a closer look.
2D vs. 3D Digital Mammography
Standard digital mammography produces flat, two-dimensional images. A newer form called digital breast tomosynthesis, often marketed as 3D mammography, takes this further. During a 3D exam, the X-ray tube sweeps in an arc over the breast, capturing multiple images from slightly different angles. Software then reconstructs these into a stack of 1-millimeter-thick slices, allowing the radiologist to scroll through the breast tissue layer by layer, much like flipping through pages of a book.
The number of slices depends on how thick your compressed breast is. This layer-by-layer view reduces the problem of overlapping tissue, which in a 2D image can either hide a real abnormality or create a false one. The result is fewer callbacks for additional imaging and improved detection of invasive cancers, particularly in dense breasts. Many facilities now offer 3D mammography as part of routine screening, sometimes alongside a standard 2D image.
Radiation Dose
A standard four-view digital mammogram delivers an effective radiation dose of about 0.5 millisieverts. For perspective, that is roughly equivalent to seven weeks of natural background radiation, the kind you absorb from the ground, air, and cosmic rays in everyday life. The dose increases slightly with thicker breast tissue because more X-ray energy is needed to penetrate the tissue. A 3D mammogram adds a small amount of additional exposure, though newer systems can generate both 2D and 3D images from a single pass, keeping the total dose comparable to a standard exam.
What Your Results Mean
Mammogram reports use a standardized scoring system called BI-RADS, which ranks findings on a scale from 0 to 6. Understanding these categories can help you make sense of the letter or online result you receive after your exam.
- BI-RADS 0: The study is incomplete. You’ll be called back for additional views or an ultrasound before the radiologist can make a final assessment.
- BI-RADS 1: Negative. No signs of cancer were found.
- BI-RADS 2: Also normal, but the radiologist noted a benign finding like a cyst. No further action needed.
- BI-RADS 3: Probably normal, but a follow-up mammogram in six months is recommended to watch a finding that has a very low chance of being cancer.
- BI-RADS 4: A suspicious finding with roughly a 23% to 34% chance of being breast cancer. A biopsy is typically recommended.
- BI-RADS 5: Highly suggestive of cancer, with about a 95% likelihood. Biopsy is recommended.
- BI-RADS 6: Assigned when cancer has already been diagnosed and the mammogram is being used to monitor treatment.
Getting a BI-RADS 0 callback is common and does not mean cancer is likely. It often just means the radiologist needs a clearer view of one area.
Breast Density Notifications
As of September 2024, all mammography facilities in the U.S. are required by federal law to include breast density information in the results they send to patients. Your report will classify your breast tissue into one of four categories: almost entirely fatty, scattered areas of density, heterogeneously dense, or extremely dense. About half of women who get mammograms have dense breasts, falling into one of the last two categories.
If your tissue is classified as dense, your results letter will include a specific notice explaining that dense tissue makes it harder to spot cancer on a mammogram and also raises your overall risk of developing breast cancer. It may suggest that additional imaging tests, such as breast ultrasound or MRI, could help find cancers that mammography alone might miss. This notification is not a diagnosis. It’s information to discuss with your healthcare provider when planning your screening approach.
How AI Fits Into the Process
Many facilities now use software tools that analyze digital mammogram images and flag areas that look suspicious. Earlier versions, called computer-aided detection (CAD), typically placed two to four markers on each screening mammogram pointing out spots the software considered worth a second look. Because only about 5 in every 1,000 screening mammograms reveal cancer, the vast majority of these markers turned out to be false alarms.
Newer systems powered by deep learning algorithms go further, assigning risk scores to flagged areas and helping radiologists prioritize which cases need the most attention. These tools are designed to assist the radiologist, not replace them. A human reader still makes the final call on every mammogram.
How to Prepare for Your Appointment
Skip deodorant, antiperspirant, powder, and lotion on the day of your mammogram. Many of these products contain metallic particles, aluminum being the most common, that show up on the image as tiny bright specks resembling calcifications. Even “natural” deodorants that use charcoal, baking soda, or zinc can leave residue that creates the same problem. If you accidentally apply any of these products, the facility will usually provide wipes so you can clean the area before imaging.
Wear a two-piece outfit so you only need to remove your top. You’ll be given a gown to wear during the exam. If your breasts tend to be tender before your period, scheduling your mammogram for the week after your period ends can make compression more comfortable.
Current Screening Recommendations
The U.S. Preventive Services Task Force updated its guidelines in 2024 to recommend screening mammography every two years for women ages 40 through 74. This was a notable change from the previous recommendation, which suggested starting at age 50 for most women. The shift reflects growing evidence that earlier screening catches cancers at more treatable stages, particularly in Black women, who have higher rates of aggressive breast cancer diagnosed before age 50. Women with additional risk factors, such as a family history of breast cancer or known genetic mutations, may benefit from starting screening earlier or adding other imaging methods to their routine.